1. Home
  2. PBHC vs LONA Comparison

PBHC vs LONA Comparison

Compare PBHC & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$16.27

Market Cap

99.5M

Sector

Finance

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$8.10

Market Cap

81.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBHC
LONA
Founded
1859
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.5M
81.5M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
PBHC
LONA
Price
$16.27
$8.10
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
4.6K
9.3K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
2.94%
N/A
EPS Growth
46.25
N/A
EPS
0.47
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$34.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$4.21
52 Week High
$17.40
$14.21

Technical Indicators

Market Signals
Indicator
PBHC
LONA
Relative Strength Index (RSI) 54.35 55.06
Support Level $15.50 $7.96
Resistance Level $17.14 $8.42
Average True Range (ATR) 0.34 0.43
MACD -0.03 0.12
Stochastic Oscillator 45.71 85.63

Price Performance

Historical Comparison
PBHC
LONA

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: